Don't Miss The World's #1 Executive Networking Event"
Home ⟩ Insights
Insights
regulations
3 min read • October 9, 2024
2024 Cannabis Taxes: States Weigh In On New Approaches To Revenue
3 min read • October 9, 2024
Buy A T-shirt, Get Busted: Loophole In Minnesota Cannabis Market Could Cost Retail Operators A 5-Year Ban
3 min read • October 9, 2024
Miami Herald Endorses Florida Cannabis Legalization, Highlights Failed Drug War, Revenue Potential
4 min read • October 8, 2024
EXCLUSIVE: Cannabis Rescheduling Is Not Cure-All For Industry Problems: Experts Explain How Tax Tactics Could Hurt Marijuana Businesses In Long Run
5 min read • October 8, 2024
It’s Your Constitutional Right: How You Can Break The Senate’s Block On Cannabis Legalization
4 min read • October 8, 2024
EXCLUSIVE: Weed Companies Will Be Treated Like Normal Businesses Once This Tax Provision Goes Away, Experts Say
1 min read • October 8, 2024
Curaleaf Executive Chairman Boris Jordan Says Both Presidential Candidate Have Come Out And Support Some Form Of Legislation Of Cannabis; Unlikely To Be Trump’s Number One Priority; Will Matter Who DOJ Head Is Under Trump Administration; Trump, In My Opinion, Will Not Overrule Them; If He Puts Someone Moderate Or Friendly It Could Be Game Changer
3 min read • October 8, 2024
100K Medical Marijuana Signatures In Nebraska Under Investigation Amid Alleged Fraud Questions
1 min read • October 8, 2024
TerrAscend Executive Chairman Jason Wild Says: Main Thrust Of Argument Is State Leader Cannabis Operators Not Considered In Violation Of Controlled Substance Act; 280E; We Want Cannabis Companies To Be Treated Like Any Industry; If And When We Win The Case, 280E Will Go Away
1 min read • October 8, 2024
Investor Ross Gerber Says: If You’re A Cannabis Investor You’re Going To Have To Be Patient; If We Reschedule That Actually Helps Companies Instantly With Their Profits; Rescheduling alone Doubles Value Of All Cannabis Companies
1 min read • October 8, 2024
Investor Ross Gerber [On Rescheduling] Says We Know [Cannabis] Is Harmless and Has Medical Benefits; We’re In This Situation; We Have Opportunity In One Month; If You Don’t Get This Done In This Cycle… We’re Going To Vote You All Out
2 min read • October 7, 2024
Joe Biden, Quick Question Before You Go: Are Those Cannabis Pardons From 2 Years Ago Still On?
Latest Headlines
View All
3 min read • September 1, 2026
Chicken Or Egg? Cannabis Brands Target Seniors As Older Americans Use More Weed
8 min read • September 1, 2026
BREAKING: House Passes One‑Month Hemp Ban Delay, Setting Up Clash Over Industry’s Future
2 min read • September 1, 2026
House Moves Toward Hemp THC Ban Delay, Giving Industry More Time Before Federal Crackdown
3 min read • September 1, 2026
Ascend Wellness Takes Step Toward U.S. Exchange Listing, Gets Green Light For Reverse Stock Split
13 min read • September 1, 2026
Boris Jordan Might Be Talking Aurora’s Dispersed Shareholder Structure Into Free-Riding the Deal
6 min read • September 1, 2026
Germany Just Ended Insurance Coverage for Cannabis Flower. Most Patients Will Keep Buying, but Not at the Price Insurers Were Paying.
4 min read • August 31, 2026
Inside DEA Marijuana Rescheduling Hearing: Key Takeaways, Part 2
5 min read • August 31, 2026
Glass House, America’s Largest Cannabis Grower by Canopy, Rings the NYSE Bell
6 min read • August 31, 2026
USCR Urges Congress to Keep the Hemp Loophole Closed
4 min read • August 28, 2026
Inside DEA Marijuana Rescheduling Hearing: Key Takeaways, Part 1
3 min read • August 28, 2026
$10 Million in Taxpayer Money Was Diverted Into Florida’s Fight Against Marijuana Legalization, Grand Jury Says
2 min read • August 28, 2026
PharmaCielo Revenue Surges 330%; European Cannabis Flower Sales Take Off
Browse By Channels
After-Hours Center
Analyst Color
Analyst Ratings
Andy Barr
Asia
Asset Sales
Be Your Own Boss
Binary Options
Biotech
Bonds
Broad U.S. Equity ETFs
Buybacks
california cannabis
Cannabis
cannabis clubs
cannabis cultivation
cannabis earnings
cannabis farms
cannabis study
CBD
Christopher Dillis
CNBC
Commodities
Congress cannabis
Congress hemp
Contracts
Crowdsourcing
Cryptocurrency
Currency ETFs
Dividends
Downgrades
Earnings
Earnings Beats
Earnings Misses
Econ #s
Economics
Education
Emerging Market ETFs
Emerging Markets
Entertainment
Entrepreneurship
Equities
ESG
ETFs
Eurozone
Events
Exclusives
Fast Money
FDA
Federal Reserve
Financial Advisors
Financing
Fintech
first quarter earnings
Forex
Futures
Gaming
General
germany cannabis
Global
Government
Guidance
Health Care
Hedge Funds
hemp bill
hemp legalization
hemp regulation
hemp rules
Hot
IgniteIt Events
illegal cannabis farms
Initiation
Insider Trades
Insurance
Interview
intoxicating hemp-derived products
Intraday Update
IPOs
James Comer
Large Cap
Latin America
Legal
Long Ideas
M&A
Macro Economic Events
Macro Notification
Management
marijuana
Market Summary
Market-Moving Exclusives
Markets
Media
Mid Cap
Movers
Movers & Shakers
New ETFs
News
Offerings
Opinion
Options
Penny Stocks
Personal Finance
Politics
Pre-Market Outlook
Press Releases
Previews
Price Target
Psychedelics
Psychology
Real Estate
Regulations
REIT
Reiteration
Rescheduling
Restaurants
Retail Sales
Reviews
Rumors
SEC
Sector ETFs
Short Ideas
Short Sellers
Signals
Small Business
Small Cap
Small Cap Analysis
Social Media
Specialty ETFs
Sports
Sports Betting
Startups
Stock Split
Success Stories
Taxes
Tech
Technicals
THC
Top Stories
Topics
Trading Ideas
Travel
UC Berkeley Cannabis Research Center
unlicensed cannabis
Upgrades
WIIM
WNBA
Join the Cannabis Revolution
Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.